Associated Papers
Typical pantothenate kinase-associated neurodegeneration caused by compound heterozygous mutations in PANK2 gene in a Chinese patient: a case report and literature review.
Tao Y et al.
Frontiers in Neurology, 2023
37188304 (PubMed )
Supplement: Table_1.XLSX › Sheet1
Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN.
Christou YP et al.
Case Reports in Neurological Medicine, 2017
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Tanteles GA et al.
Journal of the Neurological Sciences, 2014
Select a paper to view details